On a previous study of our group, it was demonstrated that higher frequencies of TLR2, TLR4, and TLR9 polymorphisms in CRC patients, in comparison to healthy individuals, are correlated with worst prognosis [20]. This evidence concerns the gene TLR4 and colorectal carcinoma.